As with aging, p53 levels also increase in WAT in type 2 diabetes, and its overexpression in rodent WAT leads to systemic insulin resistance, thus supporting the association between increased p53 levels in WAT and metabolic disorders in obesity and senescence, also related to age [60]. The gene discussed is TP53; the disease is metabolic disease.